Hongyuan Pharmaceutical: 2024 Semi-Annual Follow-up Report of Minsheng Securities Co., Ltd. on Hubei Hongyuan Pharmaceutical Technology Co., Ltd.

SZSI · Aug 30

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.